Lymphoma
Cross-source consensus on Lymphoma from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Risks & contraindications
Interactions
Evidence quality
Highlighted claims
- EQ-5D had poor criterion validity in lymphoma. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- EQ-5D should not be relied on as a standalone quality-of-life or utility instrument for lymphoma without caution. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- The weak, non-significant correlation with time trade-off raises concerns about using EQ-5D alone for lymphoma utility estimates. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- No examined patient characteristics were significantly associated with utility discrepancy in lymphoma. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China
- Anxiety/depression did not significantly load onto either structural factor in lymphoma. — Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China